Jason P. Covy - Publications

Stanford University, Palo Alto, CA 
Transynaptic Signaling, Transmembrane Proteins, Neuordegeneration, Neuropharmaclogy, Neuroscience, Synaptic Plasticity

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Patzke C, Han Y, Covy J, Yi F, Maxeiner S, Wernig M, Südhof TC. Analysis of conditional heterozygous STXBP1 mutations in human neurons. The Journal of Clinical Investigation. 125: 3560-71. PMID 26280581 DOI: 10.1172/JCI78612  0.96
2015 Anderson GR, Aoto J, Tabuchi K, Földy C, Covy J, Yee AX, Wu D, Lee SJ, Chen L, Malenka RC, Südhof TC. β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. Cell. 162: 593-606. PMID 26213384 DOI: 10.1016/j.cell.2015.06.056  0.96
2013 Bailey RM, Covy JP, Melrose HL, Rousseau L, Watkinson R, Knight J, Miles S, Farrer MJ, Dickson DW, Giasson BI, Lewis J. LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathologica. 126: 809-27. PMID 24113872 DOI: 10.1007/s00401-013-1188-4  0.96
2013 Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J, Xu W, Yang N, Danko T, Chen L, Wernig M, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 78: 785-98. PMID 23764284 DOI: 10.1016/j.neuron.2013.05.029  0.96
2012 Covy JP, Waxman EA, Giasson BI. Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants. Journal of Neuroscience Research. 90: 2306-16. PMID 22847264 DOI: 10.1002/jnr.23112  0.96
2012 Emmer KL, Covy JP, Giasson BI. Studies of protein aggregation in A53T α-synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice. Neuroscience Letters. 507: 137-42. PMID 22188655 DOI: 10.1016/j.neulet.2011.12.005  0.96
2011 Emmer KL, Waxman EA, Covy JP, Giasson BI. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. The Journal of Biological Chemistry. 286: 35104-18. PMID 21846727 DOI: 10.1074/jbc.M111.247965  0.96
2011 Covy JP, Giasson BI. α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease. Neurotoxicology. 32: 622-9. PMID 21238487 DOI: 10.1016/j.neuro.2011.01.003  0.96
2010 Covy JP, Giasson BI. The G2019S pathogenic mutation disrupts sensitivity of leucine-rich repeat kinase 2 to manganese kinase inhibition. Journal of Neurochemistry. 115: 36-46. PMID 20626563 DOI: 10.1111/j.1471-4159.2010.06894.x  0.96
2009 Waxman EA, Covy JP, Bukh I, Li X, Dawson TM, Giasson BI. Leucine-rich repeat kinase 2 expression leads to aggresome formation that is not associated with alpha-synuclein inclusions. Journal of Neuropathology and Experimental Neurology. 68: 785-96. PMID 19535993 DOI: 10.1097/NEN.0b013e3181aaf4fd  0.96
2009 Covy JP, Giasson BI. Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2. Biochemical and Biophysical Research Communications. 378: 473-7. PMID 19027715 DOI: 10.1016/j.bbrc.2008.11.048  0.96
2009 Covy JP, Yuan W, Waxman EA, Hurtig HI, Van Deerlin VM, Giasson BI. Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 32-9. PMID 19006185 DOI: 10.1002/mds.22096  0.96
2009 Covy JP, Giasson BI. Corrigendum to "Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2" [Biochem. Biophys. Res. Commun. 378 (2009) 473-477] (DOI:10.1016/j.bbrc.2008.11.048) Biochemical and Biophysical Research Communications. 387: 419-420. DOI: 10.1016/j.bbrc.2009.06.066  0.96
2006 Giasson BI, Covy JP, Bonini NM, Hurtig HI, Farrer MJ, Trojanowski JQ, Van Deerlin VM. Biochemical and pathological characterization of Lrrk2. Annals of Neurology. 59: 315-22. PMID 16437584 DOI: 10.1002/ana.20791  0.96
2006 Covy JP, Van Deerlin VM, Giasson BI. Lack of evidence for Lrrk2 in α-synuclein pathological inclusions [4] Annals of Neurology. 60: 618-619. DOI: 10.1002/ana.21029  0.96
Show low-probability matches.